공지사항

Canadian Pacific Colon Cancer Screening

CRC is the second-most frequent cause of deaths in Canada. Most cases are detected when they are advanced. Regular CRC screening using the guaiac-based blood tests for Canadian Pacific Colon Cancer fecal-occult (FOBT) and sigmoidoscopy that is flexible can cut the risk of death by 15 percent.

Research has previously revealed that immigrants in Ontario have lower rates of CRC screening than canadian pacific interstitial lung disease-born residents. This study will explore the differences in CRC screening rates between immigrants based on country of birth, region, and ethnicity.

Incidence

The second most frequent cause of death in Canada is colorectal cancer. CRC incidence is decreasing in recent years however the majority of cases diagnosed are at the stage of late-stage. The survival rate for patients diagnosed in stages III and IV is less than 10%. The majority of deaths could be avoided with routine screening and early detection.

The guidelines for screening in every province differ, but most recommend a biennial Guaiac-based fecal blood test (FOBT) or a fecal immunechemical (FIT) test for people aged 50-74 years old. People who have positive FOBT test results need to be followed up with colonoscopy. Cost-effectiveness analyses have shown that the number of deaths due to CRC can be decreased by 13% with regular tests for feces. The screening rates in Canada are not ideal 39% of eligible Ontarians have waited too long to get their next test.

Studies have shown that immigrants in Ontario Canada's largest province, are at lower risk for CRC than the general population. However, it's unclear whether differences in the level of diagnosis persist after adjustment for Canadian Pacific Colon Cancer age, sex and other factors related to healthcare. We examined data from a provincial-organized screening program, ColonCancerCheck. This program recommends an gFOBT/FIT that is based on guaiac every two years for those not having a first-degree relative who has CRC and screening colonoscopy at least once a year for those who have a family member with CRC.

Symptoms

Adenocarcinoma can be found in epithelial cells that form the rectum or colon. It can begin within the lining or in different layers, and eventually spread to other parts. Mucinous adenocarcinoma is more likely to expand rapidly and is generally more aggressive than other types of Adenocarcinoma.

It is not common to find squamous cells in the rectum and colon. It is formed in cells that make up the outer layer of the skin and other parts of the body.

Peutz-Jeghers syndrome (PJS) increases a person's risk of colorectal cancer, as well as other gastrointestinal tract cancers. PJS is an inheritable condition that causes polyps to grow in the gastrointestinal tract. These polyps can become cancerous if they aren't eliminated through screening and treatment. The symptoms of PJS include stomach pain and weight loss, as well as diarrhea.

Diagnosis

Colorectal cancer is diagnosed through a physical examination, blood work and stool samples. These tests aid doctors in determining if the cancer began in the colon or rectum, or if it has been spread to other parts of your body. Indigestion, abdominal pain, and changes in bowel or stool habits could be signs. If the symptoms are not severe, a physician may not recommend any additional tests or treatment.

The majority of canadian pacific chronic lymphocytic leukemia provinces have organized cancer screening programs for colorectal cancer. The programs utilize fecal tests, either a guaiac based blood test in the fecal area (FIT) or an occult fecal test that is which is based on the guaiac. Some programs recommend a flexible sigmoidoscopy as well as an FOBT.

In Ontario the most populous province, a newly implemented organized screening program uses an annual FOBT for risk individuals over 50 years of age. This program has led to a significant decrease in the rate of CRC. However, many people die from CRC due to being diagnosed late. This is especially true for immigrant communities and even after adjusting age, gender and healthcare-related characteristics. This is a crucial problem that needs to be addressed with targeted and scientifically-based interventions. This means increasing the number of fecal screening and increasing awareness among physicians of the importance of CRC testing for all adults.

Treatment

Regular fecal screening can help to prevent colorectal cancer, which is the second leading cause of deaths in Canada. Numerous large randomized controlled studies have demonstrated that screening using the guaiac-based fecal occult blood test (FOBT) can cut down on the incidence of CRC and death. Most canadian pacific blood cancer provinces have provincial screening programs which recommend FOBT (guaiac based or fecal immune chemical test; the FIT), flexible sigmoidoscopy or both every two years, and colonoscopy for positive results.

Despite the fact that well-organized provincial screening programs have the potential to significantly reduce the number of deaths due to CRC However, the rate of screening remains suboptimal. A recent study conducted in Ontario discovered that 39% of Ontarions who are due for screening do not receive screening. A provincial screening program for patients who are 50-74 years old is recommended regardless of the method used.

The study also found that men who were immigrants from Europe and Central Asia were more likely to be diagnosed with late stage diseases compared to their canadian pacific myelodysplastic syndrome-born counterparts. These findings suggest the need for more outreach to the immigrant population.

In addition, individuals who suffer from Peutz-Jeghers syndrome have an increased risk of developing cancer of the colorectal and might require a different screening regimen. Patients with PJS need to be regularly evaluated using low-sensitivity FOBT, the FIT, and colonoscopy examinations in their 20s. Ideally, primary care physicians should be able to screen for all patients with PJS.